Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT00565851
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-12-10
First Post:
2007-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2007-11-29
First Submit QC Date:
None
Study First Post Date:
2007-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-11-13
Results First Submit QC Date:
None
Results First Post Date:
2020-12-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL